Dr.Suat Seren Chest Diseasees Hospital
Izmir, 35230, Turkey (Türkiye)
Location status: Recruiting
Location contact
Cenk Kirakli, professor
CONTACT
NCT Number: NCT06357780
The study is a multicentric prospective randomised cross-over study. It evaluates the compatibility of patients with the device without altering the routine treatment applied. During this evaluation, either the clinician-adjusted values on the device or the standard pre-set values are used to obtain hourly and 30-minute PVA (Patient Ventilator Asynchrony) recordings. These recordings will be analysed offline to identify the settings used and to compare the hourly and 30-minute PVA (Patient Ventilator Asynchrony) values when synchronisation is automatically set. The relationships and differences between these values will be analysed. For this purpose, the IntelliSync+ option, already available on the device, will be used. This software continuously analyses waveform signals at least a hundred times per second. This allows for the immediate detection of patient efforts and the initiation of inspiration and expiration in real time, thereby replacing traditional trigger settings for inspiration and expiration. If the patient is already synchronised with this option, it will then be possible to switch to traditional synchronisation settings for comparison. Statistical analyses will be conducted using SPSS 24.0, JASP (Just Another Statistical Programme), Jamovi ( fork of JASP), or R software. Initially, all numerical and categorical data will be evaluated using descriptive statistical methods. The distributions of numerical variables will be examined using visual (histograms and probability plots) and analytical methods (Kolmogorov-Smirnov/Shapiro-Wilk tests). Mean/SD (standard deviation) or median/interquartile range (IQR) will be used as measures of distribution. For comparing numerical data that follows a normal distribution, the Student-t test will be used, and for non-normally distributed data, the Mann-Whitney U or Wilcoxon signed-rank tests will be employed. PVA (Patient Ventilator Asynchrony) values will be statistically compared. For the analysis of categorical data, the Chi-Square test will be applied. Bayesian analysis may also be used as necessary during the writing of the study. The results obtained will be interpreted and reported by the researchers. Results with a "p" value below 0.05 will be considered statistically significant.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Izmir, 35230, Turkey (Türkiye)
Location status: Recruiting
Cenk Kirakli, professor
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
30 minutes period where the pressure support of spontaneous effort will be automatically titrated based on pressure and flow waveform analysis obtained from the patient during NIV mode.
30 minutes period where the synchronization of pressure support of patient effort during NIV mode will be manually set.
Time frame: 30 minutes
[(detectable asynchronies )/(total number of breaths + ineffective efforts)]x100
Time frame: 30 minutes
[(major asynchronies)/(total number of breaths + ineffective efforts)]x100
Time frame: 30 minutes
[(minor asynchronies)/(total number of breaths + ineffective efforts)]x100
Time frame: 30 minutes
Patient subjective dyspnea scale
Contact information is provided by the study sponsor or research team.
Ramazan Guven, Associate professor
CONTACT
Tuba Dogan, MD
CONTACT
Başakşehir Çam & Sakura City Hospital
Other Gov
Closed-loop syncHronization vErsuS convenTional Synchronization in sPontaneously Breathing Adult Nonivasive Ventilation Patients (CHEST-SPAN) - a Randomized Cross-over Trial
Acronym: CHESTSPAN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06051292
Acute Respiratory Distress Syndrome, Acute Respiratory Failure
Aydin, Turkey (Türkiye)
View Trial DetailsNCT04158479
Acute Respiratory Distress Syndrome, Acute Respiratory Failure
Beijing, Beijing Municipality, China
View Trial DetailsNCT06213779
Acute Respiratory Distress Syndrome, Acute Respiratory Failure
Beijin, China
View Trial DetailsNCT04663802
ARDS, Acute Respiratory Distress Syndrome
Plainsboro, New Jersey, United States
View Trial Details